Short-term versus lifetime risk assessment for cardiovascular disease: Pros, cons, and clinical implications

Current Cardiovascular Risk Reports

Volumn 3, Issue 2, 2009, Pages 144-149

  Wilkins, John T ^b   Lloyd Jones, Donald M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855343325     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-009-0023-x     Document Type: Article

References (32)

1. Rosamond W, Flegal K, Furie K, et al.: Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117: e25-e146.
2. Murray CJL, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349: 1498-1504.
3. Mokdad AH, Ford ES, Bowman BA, et al.: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289: 76-79.
4. Jackson R: Guidelines on preventing cardiovascular disease in clinical practice. BMJ 2000, 320: 659-661.
5. Rose G: Environmental health: problems and prospects. J R Coll Physicians Lond 1991, 25: 48-52.
6. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106: 3143-3421.
7. Lloyd-Jones DM, Larson MG, Beiser A, Levy D: Lifetime risk of developing coronary heart disease. Lancet 1999, 353: 89-92.
8. Lloyd-Jones DM, Leip EP, Larson MG, et al.: Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006, 113: 791-798.
9. Smith SC, Greenland P, Grundy SM: AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: executive summary. Circulation 2000, 101: 111-116.
10. D'Agostino RB, Grundy SM, Sullivan LM, et al.: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286: 180-187.
11. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al.: General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117: 743-753.
12. Conroy RM, Pyorala K, Fitzgerald AP, et al.: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24: 987-1003.
13. Assmann G, Cullen P, Schulte H: Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002, 105: 310-315.
14. Chambless LE, Folsom AR, Sharrett AR, et al.: Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol 2003, 56: 880-890.
15. Liao Y, McGee DL, Cooper RS: Prediction of coronary heart disease mortality in blacks and whites: pooled data from two national cohorts. Am J Cardiol 1999, 84: 31-36.
16. Cavanaugh-Hussey MW, Berry JD, Lloyd-Jones DM: Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool. Prev Med 2008, 47: 619-623.
17. Daviglus ML, Stamler J, Pirzada A, et al.: Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA 2004, 292: 1588-1592.
18. Lloyd-Jones DM, Wilson PWF, Larson MG, et al.: Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol 2004, 94: 20-24.
19. Navas-Nacher EL, Colangelo L, Beam C, Greenland P: Risk factors for coronary heart disease in men 18 to 39 years of age. Ann Intern Med 2001, 134: 433-439.
20. Berry JD, Garside DB, Cai X, et al.: Remaining lifetime risks for cardiovascular disease death by risk factor burden at selected ages in black and white men and women. Circulation 2007, 116: II-832.
21. Enos W, Holmes R: Coronary disease among United States soldiers killed in action in Korea: preliminary report. JAMA 1953, 152: 1090-1093.
22. McNamara JJ, Molot MA, Stremple JF, Cutting RT: Coronary artery disease in combat casualties in Vietnam. JAMA 1971, 216: 1185-1187.
23. Berry JD, Liu K, Folsom AR, et al.: Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation 2009, 119: 382-389.
24. Beiser A, D'Agostino RB, Seshadri S, et al.: Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med 2000, 19: 1495-1522.
25. Feuer EJ, Wung L, Boring CC, et al.: The lifetime risk of developing breast cancer. J Natl Cancer Inst 1993, 85: 892-897.
26. Blackman DK, Bennett EM, Miller DS: Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)-Behavioral Risk Factor Surveillance System. MMWR CDC Surveill Summ 1999, 48(SS-6): 1-22.
27. Vasan RS, Beiser A, Seshadri S, et al.: Residual lifetime risk for developing hypertension in middle-aged women and men. JAMA 2002, 287: 1003-1010.
28. Lloyd-Jones DM, Wilson PWF, Larson MG, et al.: Lifetime risk for coronary heart disease by cholesterol levels at selected ages. Arch Intern Med 2003, 163: 1966-1972.
29. Lloyd-Jones DM, Dyer AR, Wang R, et al.: Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death. Am J Cardiol 2007, 99: 535-540.
30. McPherson R, Frohlich J, Fodor G, Genest J: Canadian Cardiovascular Society position statement-recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 2006, 22: 913-927.
31. Mosca L, Banka CL, Benjamin EJ, et al.: Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007, 115: 1481-1501.
32. Lloyd-Jones DM: Short-term versus long-term risk for coronary artery disease: implications for lipid guidelines. Curr Opin Lipidol 2006, 17: 619-625.